Drug · DIN 02566877
TREMFYA
SINGLE-USE PREFILLED PEN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 4, 2026; first marketed May 4, 2026.
- Drug Identification Number (DIN)
- 02566877
- Company (DIN owner)
- Janssen Inc.Toronto, Ontario, Canada
- Schedule
- Prescription; Schedule D
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Guselkumab L04AC16
- Class
- Human
- Record last updated
- September 17, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| GUSELKUMAB | 100 MG | ML |
Other DINs named TREMFYA
- DIN 02469758 · Marketed
- DIN 02559145 · Marketed
- DIN 02559137 · Approved
- DIN 02570890 · Approved